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Starting from (S)-tryptophanol, a formal synthesis of ent-
rhynchophylline and ent-isorhynchophylline, involving 
stereoselective cyclocondensation, spirocyclization, and 
alkylation reactions, and the final adjustment of the oxidation 10 
level at the oxindole and piperidine moieties, is reported. 
Oxindole alkaloids are a diverse group of natural products1 
characterized by the presence of a spiro[pyrrolidine-3,3’-
oxindole] ring system,2 a privileged heterocyclic motif associated 
with a variety of bioactivity profiles.3 Most of the oxindole 15 
alkaloids incorporate an unrearranged secologanin skeleton and 
are biogenetically formed by oxidative rearrangement of 
secoyohimbane- or heteroyohimbane-type indole alkaloids. 
Representative members of this group are rhynchophylline and 
isorhynchophylline (Fig.1),4 a pair of C-7 epimers that can be 20 
equilibrated through a ring-opened form via retro-
Mannich/Mannich reactions. These alkaloids exhibit a number of 
pharmacological effects5 and are the major tetracyclic oxindole 
components of Uncaria species, which have long been used in 
traditional Oriental medicine.6 25 
 
Fig. 1 
 Although the stereogenic quaternary spirocenter and the three 
stereogenic centers on the piperidine ring make rhynchophyllines 
attractively challenging synthetic targets, they have received 30 
limited attention from the synthetic standpoint.7 In fact, only two 
different strategies have been used to assemble the 
spiro[pyrrolidine-3,3’-oxindole] moiety of these alkaloids: either 
a biomimetic oxidative rearrangement from a indolo[2,3-
a]quinolizidine derivative4g,7c,d or a condensation of 2-35 
hydroxytryptamine with an appropriate aldehyde.7a,b 
 We present here an enantioselective synthesis of ent-
rhynchophylline and ent-isorhynchophylline using (S)-
tryptophanol as the starting material, which not only incorporates 
the tryptamine moiety of the natural products but also acts as the 40 
source of chirality. Our approach takes advantage of the 
methodology we have reported for the enantioselective 
spirocyclization of tryptophanol-derived oxazolopiperidone 
lactams, involving a Lewis acid-promoted cyclization of the 
corresponding Nind-tosyl derivatives in the presence of Et3SiH.
8 
45 
Scheme 1 outlines the initial steps of the synthesis and the overall 
synthetic strategy.  
 The required bicyclic lactam 2, which already incorporates an 
acetate chain at the 4-position of the piperidone ring, was 
prepared9 by cyclocondensation of (S)-tryptophanol with the 50 
prochiral aldehyde-diester 1, in a process that involves the 
enantioselective desymmetrization10 of two enantiotopic chains.11 
The N-indole deactivating group, needed to direct the key 
cyclization on the indole 3-position, was benzenesulfonyl,12 
which was introduced in excellent yield under conventional solid-55 
liquid phase transfer conditions. Treatment of sulfonyl derivative 
3 with TiCl4 in the presence of Et3SiH resulted in a regio- and 
stereocontrolled cyclization, with concomitant reduction of the 
initially formed spiroindoleninium intermediate, leading to the 
tetracyclic spiroindoline 4 as a single stereoisomer in 93% yield. 60 
Interestingly, 4 already embodies three of the four stereogenic 
centers of the target natural products, with the appropriate relative 
configuration. 
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Scheme 1 Initial steps of the synthesis and synthetic strategy. Reagents 
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and conditions: (a) Toluene, Dean-Stark, reflux, 24 h, 65% (7,8a-epi-2, 
10%); (b) 30% NaOH, Bu4NCl, PhSO2Cl, CH2Cl2, rt, 20 h, 90%; (c) 
Et3SiH, TiCl4, CH2Cl2, reflux, 20 h, 93%. 
 
 As outlined in Scheme 1, the synthesis of rhynchophyllines 5 
from the spiroindoline 4 would involve the following 
transformations: i) removal of the hydroxymethyl group, ii) 
stereoselective introduction of the C-20 ethyl substituent to obtain 
the required trans C15-C20 stereochemistry, iii) oxidation of the 
indoline moiety to the oxindole functionality, iv) chemoselective 10 
reduction of the lactam carbonyl, and finally, v) introduction of 
the C-16 methoxyvinyl appendage. 
 The removal of the hydroxymethyl substituent, which has 
acted as an element of stereocontrol during the spirocyclization 
step, was accomplished by oxidation to a carboxylic acid, 15 
followed by a radical reductive decarbonylation via a 
selenoester13 to give the tetracyclic lactam 5 (Scheme 2). 
 
 
 20 
Scheme 2 Formal enantioselective synthesis of ent-rhynchophylline and 
ent-isorhynchophylline. Reagents and conditions:(a) IBX, DMSO, rt, 20 
h, 79%; (b) NaClO2, NaH2PO4, CH3CN, t-BuOH, H2O, 1-
methylcyclohexene, rt, 1 h, then (PhSe)2, n-PBu3, CH2Cl2, reflux, 16 h, 
64%; (c) AIBN, n-Bu3SnH, benzene, reflux, 1 h, 65%; (d) LiBH4, Et2O, 25 
reflux, 48 h, 83%; (e) NaH, THF, rt, 2 h, then MPMCl, Bu4NI, reflux, 16 
h, 87%; (f) KHMDS, THF, rt, 2 h, then EtI, HMPA, rt, 16 h, 72% (20-epi-
7, 19%); (g) DDQ, CH2Cl2/H2O, rt, 1 h, 93%; (h) IBX, DMSO, rt, 20 h; 
(i) NaClO2, NaH2PO4, CH3CN, t-BuOH, H2O, 1-Me-1-Chx, rt, 1.5 h, then 
Me3SiCl, MeOH, rt, 24 h, 66% (three steps); (j) Na/Hg 5%, NaH2PO4, 30 
MeOH, 0 ºC, 15 min, 88%; (k) PhIO, CH2Cl2, rt, 48 h, 70%; (l) AlH3, 
THF, –78 ºC (addition) to –50 ºC, 30 min, then MeOH, rt, 20 min, then 
NaBH3CN, AcOH, rt, 20 min, 47%. 
 
 At this point, to complete the carbon skeleton of 11, a known7b 35 
synthetic precursor of rhynchophyllines, only the introduction of 
the C-20 ethyl substituent remained to be done. However, to 
avoid the competitive alkylation at the α-position of the ester 
group, the alkylation was performed from the protected alcohol 
derivative 6, which was obtained in good yield by LiBH4 40 
reduction of 5 followed by protection with p-methoxybenzyl 
chloride. The alkylation of 6 was performed with ethyl iodide, 
using KHMDS as the base and HMPA as the cosolvent, to 
stereoselectively give the expected trans-3,4-disubstituted 2-
piperidone derivative 7.14 Then, the C-15 acetate chain was 45 
reinstalled (compound 8) by oxidative removal of the p-
methoxybenzyl protecting group of 7 with DDQ, followed by 
oxidation of the resulting alcohol to a carboxylic acid and a 
subsequent esterification. After a smooth and efficient 
deprotection of the indoline nitrogen with 5% Na/Hg, 50 
spiroindoline 9 was oxidized with PhIO, leading to oxindole 10 in 
70% yield. Finally, chemoselective reduction of the six-
membered lactam carbonyl, without affecting the oxindole 
moiety, was satisfactorily accomplished by sequential treatment 
of 10 with AlH3 and NaBH3CN.
15 The resulting oxindole 11 55 
showed 1H- and 13C-NMR spectral data coincident with those 
reported7c for rac-11. Taking into account that rac-11 has 
previously been converted7b to (±)-rhynchophylline and (±)-
isorhynchophylline, the synthesis of oxindole 11 constitutes a 
formal enantioselective synthesis of the non-natural enantiomers 60 
of these alkaloids. 
 The results reported herein further illustrate the potential of 
tryptophanol-derived oxazolopiperidone lactams for the 
enantioselective synthesis of indole alkaloids.16 Two notable 
aspects of the synthesis are the efficient, highly convergent, and 65 
totally stereoselective assembling of the tetracyclic 
spiro[indoline-3,1’-indolizidine] ring system of rhynchophyllines 
and the generation of the required oxindole functionality by 
oxidation of an N-unsubstituted indoline.17 
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